Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

Historical Holders from Q2 2015 to Q3 2025

Symbol: BPMC
Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 65M
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 26.1K
Holdings value: $2.58M
% of all portfolios: 0%
Grand Portfolio weight change: -0.013%
Number of holders: 5
Number of buys: 1
Number of sells: -340
Average Value change %: -0.04%
Average buys %: +0%
Average sells %: -0.038%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	8%		$438M		5.09M		BlackRock, Inc.	31 Mar 2025
Pentwater Capital Management LP	6%		$501M		3.9M		Pentwater Capital Management LP	30 Jun 2025
WELLINGTON MANAGEMENT GROUP LLP	4.8%		$265M		3.07M		Wellington Management Group LLP	31 Mar 2025
FMR LLC	3.5%		$194M		2.25M		FMR LLC	31 Dec 2024
PRICE T ROWE ASSOCIATES INC /MD/	2.3%		$188M		1.47M		T. Rowe Price Associates, Inc.	30 Jun 2025
Avoro Capital Advisors LLC	0.6%	-90%	$48.2M	-$447M	375K	-90.3%	Avoro Capital Advisors LLC	30 Jun 2025

Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	26.1K	$2.58M	-$8.23B	0	0	$128.79	5
2025 Q2	64.3M	$8.24B	-$129M	196M	125M	$128.18	351
2025 Q1	68.5M	$6.06B	+$140M	93.2M	137M	$88.51	348
2024 Q4	67.1M	$5.85B	+$127M	121M	139M	$87.22	336
2024 Q3	65.3M	$6.04B	-$164M	109M	208M	$92.50	315
2024 Q2	66.3M	$7.15B	+$48.4M	60.2M	114M	$107.78	302
2024 Q1	65.8M	$6.24B	+$177M	65.5M	67.3M	$94.86	278
2023 Q4	64.1M	$5.91B	-$46.6M	52.8M	73.3M	$92.24	255
2023 Q3	64.7M	$3.25B	+$14.3M	22.3M	7.86M	$50.22	217
2023 Q2	63.6M	$4.02B	+$55.2M	24.5M	9.44M	$63.20	216
2023 Q1	63.3M	$2.84B	+$37.4M	15.1M	6.49M	$44.99	211
2022 Q4	62.7M	$2.75B	-$81.3M	9.82M	5.69M	$43.81	217
2022 Q3	63M	$4.15B	-$129M	8.53M	14.9M	$65.89	225
2022 Q2	63.2M	$3.19B	+$153M	9.44M	21.8M	$50.51	217
2022 Q1	59.8M	$3.82B	-$49M	6.59M	11.3M	$63.88	230
2021 Q4	59M	$6.32B	-$30.9M	9.95M	6.31M	$107.11	268
2021 Q3	59.6M	$6.13B	+$117M	16.9M	36.6M	$102.81	277
2021 Q2	58.5M	$5.14B	-$35.1M	12.8M	8.51M	$87.96	271
2021 Q1	58.5M	$5.69B	+$111M	16M	6.79M	$97.23	253
2020 Q4	57.6M	$6.46B	+$68.8M	54.2M	19.8M	$112.15	271
2020 Q3	56.9M	$5.27B	+$134M	19.3M	21.5M	$92.70	233
2020 Q2	56.2M	$4.39B	+$150M	53M	37.2M	$78.00	227
2020 Q1	54.5M	$3.19B	+$194M	26.2M	28.6M	$58.48	203
2019 Q4	50.7M	$4.06B	-$62.8M	51.6M	34.5M	$80.11	221
2019 Q3	51.4M	$3.78B	+$140M	27.9M	82.5M	$73.47	212
2019 Q2	49.6M	$4.68B	+$325M	33.1M	56M	$94.33	217
2019 Q1	48.5M	$3.88B	+$227M	16.8M	14.2M	$80.05	200
2018 Q4	45.7M	$2.46B	-$75.5M	6.02M	7.75M	$53.91	157
2018 Q3	44.9M	$3.5B	+$29M	16.5M	9.68M	$78.06	186
2018 Q2	44.8M	$2.84B	+$140M	17.1M	33.4M	$63.48	177
2018 Q1	41.2M	$3.78B	+$79.7M	13.7M	13.6M	$91.70	173
2017 Q4	42.8M	$3.23B	+$311M	5.55M	18.2M	$75.41	166
2017 Q3	36.3M	$2.53B	+$26.6M	2.63M	3.44M	$69.67	134
2017 Q2	35.6M	$1.8B	+$79M	4.26M	2.73M	$50.67	123
2017 Q1	34.7M	$1.39B	+$417M	1.81M	2.81M	$39.99	133
2016 Q4	26M	$730M	+$173M	363K	348K	$28.05	101
2016 Q3	19.2M	$569M	+$16.1M	276K	293K	$29.70	87
2016 Q2	19.5M	$395M	+$32.9M		0	$20.25	82
2016 Q1	17.9M	$323M	-$4.07M		5.96M	$18.05	70
2015 Q4	18M	$474M	+$22.3M		11.5M	$26.34	72
2015 Q3	23.9M	$509M	+$16.1M			$21.34	70
2015 Q2	23.2M	$611M	+$610M			$26.49	70